In conclusion, the germinal and somatic CDKN1B mutations reported with increasing frequency in the literature and variant databases suggest that p27 alterations may play a direct role in hormone-related diseases and cancers that are hormone-dependent or hormone-responsive. Here, CDKN1B is linked to cancer.